Analysis Plant Health Care Plc (PLHCF)
5/30/2024
Analysis of Plant Health Care Plc (PLHCF)
Plant Health Care Plc (PLHCF) is currently trading at a price of 0.03. The Relative Strength Index (RSI) is at 41.50, indicating a neutral position. The Moving Average Convergence Divergence (MACD) shows a value of 0.00111, with the signal line at 0.00132 and the histogram at -0.00022, suggesting a potential bearish signal.Looking at the Moving Averages, the Simple Moving Average (SMA) is at 0.038, the Exponential Moving Average (EMA) is at 0.03514, and the Weighted Moving Average (WMA) is at 0.03660. The current price is below the SMAs, indicating a bearish trend.
In summary, based on the RSI, MACD, and Moving Averages, Plant Health Care Plc is currently showing signs of a bearish trend. Traders and investors may want to exercise caution and monitor the stock closely for any potential changes in the trend.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It is important to note that these are analyst estimates and actual performance may vary.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The results for the quarter ending on January 31, 2025, were released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive profit margin and healthy return on assets and equity. The balance sheet shows a decent current ratio, but a relatively high total debt to equity ratio. The income statement indicates significant revenue and EBITDA, with a good gross profit margin and earnings per share.
Moving on to stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows a beta above 1, with the stock trading within a range of fifty-two-week low and high prices.
Valuation metrics suggest a relatively high PEG ratio and forward PE ratio, with the stock being valued at a premium based on price to book, price to sales, and enterprise value multiples.
Lastly, the dividends and splits information reveals details about dividend payments, dividend yields, and historical stock splits for the company.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, showing a healthy growth in profitability.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to maintain a healthy EBITDA margin over the years, indicating strong operational performance.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving.
Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2020 at $65,339,000,000.
6. The company has been relying more on non-current liabilities over the years.
7. Cash and cash equivalents have been fluctuating in the current assets.
8. Investments and advances in non-current assets have been increasing consistently.
9. Machinery, furniture, and equipment values have been fluctuating in non-current assets.
10. Retained earnings have been both positive and negative in different years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show significant fluctuations, with large amounts being spent on common stock repurchase and debt issuance and payments.
4. Investing activities also vary, with notable amounts spent on the sale and purchase of investments, as well as capital expenditures.
5. The end cash position has been fluctuating, but overall, the company has maintained a healthy cash reserve.
6. Interest paid has also varied over the years, reflecting changes in the company's debt structure.
7. Income tax paid has shown fluctuations, possibly due to changes in tax regulations or the company's financial performance.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year. The estimates range from $1.44 to $1.63, based on 25 analysts' forecasts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, an increase from the previous year's EPS of $6.13. The analysts' estimates range from $6.43 to $6.92, with insights from 39 analysts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is projected to be $7.23, compared to the previous year's EPS of $6.59. The EPS estimates range from $6.40 to $7.90, based on forecasts from 39 analysts.
Overall, the analysts are generally optimistic about the company's future earnings per share, with expected growth in both the quarterly and annual results over the coming years.
MACD of PLHCF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
